Business · 21/06/1999Updated: 10/17/2026 · 1 min read
SoloPak Laboratories, Inc. Seeks Withdrawal of FDA Approval for 39 Drug Applications
Summary
SoloPak Laboratories, Inc. has requested the FDA to withdraw approval of 1 new drug application and 38 abbreviated new drug applications, citing that the corresponding drug products are no longer marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →